top of page
The Professional Network for Healthcare Experts
Bayer Secures €3bn Apollo Investment in Contraceptives Business as Pharma Strategy Evolves
The deal gives Bayer additional financial flexibility while allowing the company to retain operational control of its long-acting reversible contraceptives portfolio.
nuaxia
Jul 133 min read
Bayer Expands Ophthalmology Pipeline with $2.45B Perfuse Therapeutics Acquisition
Deal strengthens Bayer’s position in retinal disease and glaucoma as long-acting ophthalmology therapies attract growing investment.
nuaxia
May 71 min read
bottom of page